Skip to main content
Top

Drugs

Issue 2/2023

Content (6 Articles)

Emerging Options for the Prevention and Management of Clostridioides difficile Infection

Anne J. Gonzales-Luna, Travis J. Carlson, Kevin W. Garey

Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management

Dario Roccatello, Savino Sciascia, Daniela Rossi, Roberta Fenoglio

Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes

Julia Flammer, Tradite Neziraj, Stephan Rüegg, Anne-Katrin Pröbstel

Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies

Niels A. D. Guchelaar, Bo J. Noordman, Stijn L. W. Koolen, Bianca Mostert, Eva V. E. Madsen, Jacobus W. A. Burger, Alexandra R. M. Brandt-Kerkhof, Geert-Jan Creemers, Ignace H. J. T. de Hingh, Misha Luyer, Sander Bins, Esther van Meerten, Sjoerd M. Lagarde, Cornelis Verhoef, Bas P. L. Wijnhoven, Ron. H. J. Mathijssen

Rezvilutamide: First Approval

Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images